National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease
National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease is a paper indexed in PICO Portal from OpenAlex.
How many citations does National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease have?
National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease has 270 citations in the OpenAlex counts PICO Portal stores.
When was National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease published?
National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease has 2008 year in the PICO Portal index.
What is the open-access status of National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease?
National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease has closed oa status in the PICO Portal index.
What is the DOI of National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease?
The DOI for National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease is on the source record.
What is the PMID of National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease?
The PMID for National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease is on the source record.
What is the OpenAlex record for National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease?
The OpenAlex for National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease is on the source record.